Cargando…

Investigating the Causes for Decreased Levels of Glutathione in Individuals with Type II Diabetes

Tuberculosis (TB) remains an eminent global burden with one third of the world’s population latently infected with Mycobacterium tuberculosis (M. tb). Individuals with compromised immune systems are especially vulnerable to M. tb infection. In fact, individuals with Type 2 Diabetes Mellitus (T2DM) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lagman, Minette, Ly, Judy, Saing, Tommy, Kaur Singh, Manpreet, Vera Tudela, Enrique, Morris, Devin, Chi, Po-Ting, Ochoa, Cesar, Sathananthan, Airani, Venketaraman, Vishwanath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366217/ https://www.ncbi.nlm.nih.gov/pubmed/25790445 http://dx.doi.org/10.1371/journal.pone.0118436

Ejemplares similares

Liposomal Glutathione Supplementation Restores T(H)1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals
por: Ly, Judy, et al.
Publicado: (2015)

Analysis of glutathione levels in the brain tissue samples from HIV-1-positive individuals and subject with Alzheimer's disease and its implication in the pathophysiology of the disease process
por: Saing, Tommy, et al.
Publicado: (2016)

Glutathione synthesis is compromised in erythrocytes from individuals with HIV
por: Morris, Devin, et al.
Publicado: (2014)

An Elucidation of Neutrophil Functions against Mycobacterium tuberculosis Infection
por: Morris, Devin, et al.
Publicado: (2013)

Unveiling the Mechanisms for Decreased Glutathione in Individuals with HIV Infection
por: Morris, Devin, et al.
Publicado: (2012)

Restoring Cytokine Balance in HIV-Positive Individuals with Low CD4 T Cell Counts
por: Valdivia, Anddre, et al.
Publicado: (2017)

The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering The Immune Responses Against Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis
por: Teskey, Garrett, et al.
Publicado: (2018)

Data on pro-inflammatory cytokines IL-1β, IL-17, and IL-6 in the peripheral blood of HIV-infected individuals
por: Saing, Tommy, et al.
Publicado: (2016)

Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection
por: Islamoglu, Hicret, et al.
Publicado: (2018)

Glutathione Supplementation as an Adjunctive Therapy in COVID-19
por: Guloyan, Vika, et al.
Publicado: (2020)

Flavonoid Mixture Inhibits Mycobacterium tuberculosis Survival and Infectivity
por: Cao, Ruoqiong, et al.
Publicado: (2019)

Glutathione and Adaptive Immune Responses against Mycobacterium tuberculosis Infection in Healthy and HIV Infected Individuals
por: Guerra, Carlos, et al.
Publicado: (2011)

The Role of Glutathione in Prevention of COVID-19 Immunothrombosis: A Review
por: Glassman, Ira, et al.
Publicado: (2023)

The association of pulmonary fibrosis with diabetes mellitus
por: Jeganathan, Niranjan, et al.
Publicado: (2020)

Glutathione Modulates Efficacious Changes in the Immune Response against Tuberculosis
por: Abnousian, Arbi, et al.
Publicado: (2023)

SUN-691 Type 2 Diabetes Management in the Context of Smith-Magenis Syndrome: Case Report
por: Mulvaney, Kylie Tamm, et al.
Publicado: (2020)

Liposomes as Carriers for the Delivery of Efavirenz in Combination with Glutathione—An Approach to Combat Opportunistic Infections
por: Kenchappa, Vanaja, et al.
Publicado: (2022)

Potential Role of Glutathione Antioxidant Pathways in the Pathophysiology and Adjunct Treatment of Psychiatric Disorders
por: Poladian, Nicole, et al.
Publicado: (2023)

Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection
por: Guilford, Timothy, et al.
Publicado: (2010)

Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis
por: Cao, Ruoqiong, et al.
Publicado: (2018)

Understanding the Relationship between Glutathione, TGF-β, and Vitamin D in Combating Mycobacterium tuberculosis Infections
por: Singh, Mohkam, et al.
Publicado: (2020)

Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione
por: Allen, Michael, et al.
Publicado: (2015)

Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects
por: Venketaraman, Vishwanath, et al.
Publicado: (2006)

Topical Absorption of Glutathione–Cyclodextrin Nanoparticle Complex in Healthy Human Subjects Improves Immune Response against Mycobacterium avium Infection
por: Sasaninia, Kayvan, et al.
Publicado: (2023)

Diabetes-Associated Common Genetic Variation and Its Association With GLP-1 Concentrations and Response to Exogenous GLP-1
por: Smushkin, Galina, et al.
Publicado: (2012)

Elucidating the Efficacy of the Bacille Calmette–Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal Glutathione
por: Abrahem, Rachel, et al.
Publicado: (2019)

Bilateral Diffuse Leukoencephalopathy in an Electrocuted Patient Where the Brain Was Not in the Pathway of Conduction
por: Jacobs, Jamie, et al.
Publicado: (2023)

Editorial: Causes for Increased Susceptibility to Mycobacterium tuberculosis – A Close View of the Immune System
por: Venketaraman, Vishwanath
Publicado: (2015)

Recent Advances in Mycobacterial Research
por: Venketaraman, Vishwanath
Publicado: (2020)

Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

Type 2 Diabetes Contributes to Altered Adaptive Immune Responses and Vascular Inflammation in Patients With SARS-CoV-2 Infection
por: Singh, Manpreet, et al.
Publicado: (2022)

Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs
por: Kachour, Nala, et al.
Publicado: (2022)

Characterization of Dendritic Cell and Regulatory T Cell Functions against Mycobacterium tuberculosis Infection
por: Morris, Devin, et al.
Publicado: (2013)

SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations
por: Rangchaikul, Patrida, et al.
Publicado: (2021)

Mycobacterium tuberculosis
por: Venketaraman, Vishwanath, et al.
Publicado: (2015)

Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection
por: Warren, Eric, et al.
Publicado: (2017)

A Role of Intracellular Toll-Like Receptors (3, 7, and 9) in Response to Mycobacterium tuberculosis and Co-Infection with HIV
por: Nguyen, Huy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v31f3bc0k5m7iep679av1dl86o